Drug
Aramchol clinical trials
Also written arachidyl amido cholanoic acid.
Includes 1 study of Aramchol meglumine.
- studies test it
- 12
- open now
- 1
- in phase 3
- 0
- first study started
- 2008
Keep track of what changes. Save the aramchol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
- Aramchol
- 11
Other names
Studies by the year they started
12 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 1
Galmed Pharmaceuticals Ltd (8) · Galmed Medical Reserch (2) · Galmed Research and Development, Ltd. (1) · University of California, San Diego (1)
Studies
Open first, then newest update. How each study uses aramchol is read from its arms, and is right about nine times in ten.
Testing it · 12
- Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine TabletRecruitingPhase 1Galmed Pharmaceuticals LtdNCT07251712Written as Aramchol
- A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing CholangitisWithdrawnPhase 2Galmed Pharmaceuticals LtdNCT06095986Written as Aramchol meglumine
- An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of AramcholCompletedPhase 1Galmed Pharmaceuticals LtdNCT05874336Written as Aramchol
- A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHCompletedPhase 2Galmed Research and Development, Ltd.NCT02279524Written as Aramchol
- Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyCompletedPhase 2University of California, San DiegoNCT02684591Written as Aramchol
- Study of Potential for Drug Interactions Mediated by CYP3A4 Inhibition With Aramchol in Healthy VolunteersCompletedPhase 1Galmed Pharmaceuticals LtdNCT03760848Written as Aramchol
- Comparison of Aramchol Concentrations With Once or Twice Daily DosingCompletedPhase 1Galmed Pharmaceuticals LtdNCT03774173Written as Aramchol
- Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese VolunteersCompletedPhase 1Galmed Pharmaceuticals LtdNCT02803996Written as Aramchol
- Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa StudyTerminatedPhase 2Galmed Pharmaceuticals LtdNCT02325492Written as Aramchol
- Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol and Food Effect in Healthy VolunteersCompletedPhase 1Galmed Pharmaceuticals LtdNCT02374437Written as Aramchol
- Study of Aramchol in Patients With Fatty Liver Disease or Nonalcoholic SteatohepatitisCompletedPhase 2Galmed Medical ReserchNCT01094158Written as Aramchol
- A Phase 1 Single and Multiple-Dose Study of Aramchol in Healthy Male VolunteersCompletedPhase 1Galmed Medical ReserchNCT00776841Written as Aramchol
Given in every arm · 1 — aramchol is usual care beside what is tested
Codes
What other systems call aramchol · ClinicalTrials.gg INT004443
- MeSH (NLM) C455117aramcholOne source NLM
- UNII (FDA) QE1Q24M65YICOMIDOCHOLIC ACIDConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C455117 | aramchol | One source NLM |
| UNII (FDA) | QE1Q24M65Y | ICOMIDOCHOLIC ACID | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.